Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
NO_LONGER_AVAILABLE
Status
Conditions
- Pulmonary Arterial Hypertension
Interventions
- DRUG: sildenafil (Revatio) 20 mg TID
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.